SEATTLE, WA–(Marketwired – Jul 20, 2017) – CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article on Medical Marijuana Inc.’s (OTC PINK: MJNA) Kannaway® subsidiary and its record monthly sales in June.
Medical Marijuana recently reported second quarter gross revenue that grew 269% to $6,131,415 and year-to-date revenue that increased 203% to $9,651,088. With its largest single month of revenue ever, Kannaway® was a key contributor to the successful quarter.
“As a well-known Company of Firsts, we are encouraged to see the company achieve a new milestone — hitting its highest revenue mark ever in this last financial quarter,” said Medical Marijuana Inc. CEO Dr. Stuart Titus in a recent press release. “We continue to work closely with our portfolio companies to ensure their success, and look forward to breaking new records as we continue to expand our footprint in new markets.”
“We are confident that Kannaway® is on a trajectory that continues to exceed expectations,” said Kannaway® CEO Black Schroeder in the same press release detailing the growth. “We are proud to be a part of the Medical Marijuana Inc. family, which actively supports efforts to increase access to cannabidiol (CBD) products worldwide.”
In addition to Kannaway®, the company owns several other subsidiaries involved in many areas of the cannabis industry. These businesses include its HempMeds businesses focused on the development of hemp-based CBD products and its stake in AXIM Biotechnologies Inc. — a pharmaceutical company developing chewable cannabinoid products designed to treat several different medical conditions.
Kannaway® is a lifestyle brand focused on all-natural ingredients, including high-quality cannabidiol-rich (CBD) hemp oil. These products are manufactured from a full-spectrum cannabinoid blend extracted from harvested hemp plants and packaged pure, with no other ingredients